Form 4: Instil Bio CFO Sandeep Laumas Acquires 45,000 Employee Stock Options
SEC Form 4 Filing
Sandeep Laumas, CFO and CBO of Instil Bio, Inc., acquired 45,000 employee stock options on September 18, 2024.
Summary
- On September 18, 2024, Sandeep Laumas, the CFO and CBO of Instil Bio, Inc., acquired 45,000 employee stock options.
- The exercise price of these options is $66.1.
- The options vest over time, with 25% vesting on September 18, 2025, and the remaining shares vesting in 36 equal monthly installments thereafter, contingent upon continued service.
- The expiration date for these options is September 17, 2034.
- Following the transaction, Laumas directly owns 45,000 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral event, reflecting standard executive compensation practices. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This is a standard Form 4 filing, reflecting a change in beneficial ownership of securities by a company insider. It's a routine part of executive compensation and doesn't necessarily indicate a significant shift in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 09/18/2024 | Date of earliest transaction: Sandeep Laumas acquired 45,000 employee stock options. |
| 09/18/2025 | 25% of the acquired stock options vest. |
| 09/17/2034 | Expiration date of the acquired stock options. |
| 09/23/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.